SEC Contract Filing

Filing Date: 2023-11-28

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d610145dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">

<IMG SRC="g610145dsp14a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;22, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cameron Turtle </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: Amended and Restated Employment Letter
Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Cameron: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Aeglea
BioTherapeutics, Inc. (the &#147;<U>Company</U>&#148;), I am very pleased to offer you a position as Chief Executive Officer of the Company (the &#147;<U>Role</U>&#148;) pursuant to this letter agreement (the &#147;<U>Agreement</U>&#148;), provided
you accept such offer as indicated by your signature below, to be effective November&nbsp;22, 2023 (the &#147;<U>Effective Date</U>&#148;). This Agreement amends and restates that certain letter agreement date June&nbsp;22, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Position</B>. While serving in the Role, you will report to the Board of Directors of the Company (the &#147;Board&#148;). You will have such duties,
authorities, and responsibilities as are customarily associated with the Role. This is a full-time employment position. It is understood and agreed that you will not engage in any other employment, consulting or other business activities (whether
full-time or part-time), except as expressly authorized in writing by the Company. Notwithstanding the foregoing, you may engage in religious, charitable and other community activities so long as such activities do not unreasonably interfere or
conflict with your obligations to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Base Salary</B>. Upon and following the Effective Date, as cash compensation for your services, the
Company will pay you an initial base salary of $625,000 per year, payable in accordance with the Company&#146;s standard payroll schedule and subject to applicable deductions and withholdings. Your base salary will be subject to periodic review and
potential adjustment in the Company&#146;s discretion. Your base salary in effect at any given time is referred to herein as the &#147;<U>Base Salary</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Annual Bonus</B>. You will continue to be eligible to receive an annual performance bonus targeted at 55% of your Base Salary. The target annual bonus
in effect at any given time is referred to herein as &#147;<U>Target Bonus</U>.&#148; Your 2023 annual bonus will be prorated based on your period of employment with the Company. The actual bonus amount is discretionary and may be subject to
achievement of performance targets established by the Company for such year. To earn an annual bonus, you must be (except as otherwise provided herein) employed by the Company as of the payment date of such bonus. Any annual bonus will be paid no
later than March 15th of the calendar year following the calendar year to which such bonus relates. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">

<IMG SRC="g610145dsp14b.jpg" ALT="LOGO">
 </P>
</DIV></Center>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">

<IMG SRC="g610145dsp14a.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Equity Grant</B>. Subject to approval by the Board or the Compensation Committee of the Board, as soon
as practicable following the Effective Date, the Company will grant you stock options to purchase 374,000 shares of the Company&#146;s common stock with an exercise price equal to the fair market value of the underlying shares on the date of grant
as determined by the Board or the Compensation Committee of the Board (the &#147;<U>Options</U>&#148;). The Options will vest over a four year period following your grant date, with 25% of the Options vesting on the first anniversary of the grant
date, and the remainder vesting in 36 equal monthly installments on each monthly anniversary thereafter, in each case, subject to your continued services with the Company through the applicable vesting dates. The Options will be governed by the
terms of the related award agreements, the Company&#146;s 2016 Equity Incentive Plan and the terms and conditions approved by the Board or the Compensation Committee of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Benefits/Paid Time Off. </B>You will continue to be eligible, subject to the terms of the applicable plans and programs, to participate in the employee
benefits and insurance programs generally made available to the Company&#146;s full-time employees. Details of such benefits programs, including applicable employee contributions and waiting periods, if applicable, will be made avail